Industry Insights & News 2018-10-28T20:05:45+00:00

Industry News

News & Statements

The Digital Therapeutics Alliance convenes thought leaders from across the industry – including DTx companies, patients, healthcare providers, payers, and industry partners – to establish foundational best practices and frameworks related to DTx product validation, operations, value, and regulatory oversight.

Load More Posts

Industry Insights

Digital therapeutics form an independent category of evidence-based products within the broader digital health landscape. These products are distinguished from other digital health categories by their primary function of delivering software-generated therapeutic interventions directly to patients to prevent, manage, or treat a medical disorder or disease. DTx products will increasingly influence the way healthcare is delivered and consumed across the world.

These Are The Digital Pills Coming To A Pharmacy Near You

Fast Company (Steven Melendez) -- While some have expressed concerns about patient privacy, proponents say new pills that track when you take them could be just the beginning for edible technology. A “digital pill” approved by [...]

Voluntis to integrate Insulia with Onduo virtual diabetes clinic

Voluntis announced that it will be integrating Insulia® into Onduo's virtual diabetes clinic. Onduo, a new diabetes management company created by Verily (an Alphabet Company) and Sanofi, is developing a virtual platform that integrates hardware, such [...]

Load More Posts

DTx Research & Studies

Digital therapeutics present the market with evidence-based technologies that have the ability to elevate medical best practices, address unmet medical needs, expand healthcare access, and improve clinical and health economic outcomes.

Load More Posts

Stay Up To Date

SIGN UP FOR DTA NEWS & UPDATES

Sign Up Now